Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 64 | 15.3% |
| Current Price (08/12) | $157.08 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 3,300.4 | |||
| Sales Growth Forecast | 12.4% | |||
| Net Profit Margin | 30.2% | |||
| Projected Shares Outstanding | 69.92 | |||
| EPS - Five year Forecast | $25.60 | |||
| Average P/E Ratio | 12.5 | |||
| Projected Average Price | $320.06 | |||
| Price Appreciation (Annualized) | 15.3% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 15.3% | |||
| Quality | ||||
| Financial Strength | 69 | 17.3 | ||
| EPS Stability | 60 | 15.0 | ||
| Industry Sales Growth Rate | 15.0% | 10.4 | ||
| Industry Net Profit Margin | 30.0% | 12.6 | ||
| Calculated Quality Rating | 55.2 | |||
| Fool CAPS | ||||
Total Players
287
Outperforms
66
Underperforms
All-Stars (64)
50
Outperforms (78%)
14
Underperforms
|
||||
| Fundamental Data Updated: 06/03/2022 | ||||